Sequential Therapy versus Triple Therapy for the First Line Treatment of Helicobacter pylori in Korea: A Nationwide Randomized Trial

Ultimate eradication rate ofHelicobacter pyloriafter first, second, or third-line therapy in Korea

(2015) Kichul Yoon et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Pretreatment Antimicrobial Susceptibility-Guided Vs. Clarithromycin-Based Triple Therapy for Helicobacter pylori Eradication in a Region With High Rates of Multiple Drug Resistance

(2014) Chung-Su Park et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Meta-Analysis of First-Line Triple Therapy for Helicobacter pylori Eradication in Korea: Is It Time to Change?

(2014) Eun Jeong Gong et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Helicobacter pylori eradication with moxifloxacin-containing therapy following failed first-line therapies in South Korea

(2014) Kyu Keun Kang   WORLD JOURNAL OF GASTROENTEROLOGY

Evidence-based recommendations for successfulHelicobacter pyloritreatment

(2014) Jeng-Yih Wu et al.   Expert Review of Gastroenterology & Hepatology

Meta-analysis: Sequential Therapy Appears Superior to Standard Therapy for Helicobacter pylori Infection in Patients Naive to Treatment

(2013) Nadim S. Jafri   ANNALS OF INTERNAL MEDICINE

Rational Helicobacter pylori Therapy: Evidence-Based Medicine Rather Than Medicine-Based Evidence

(2013) David Y. Graham et al.   Clinical Gastroenterology and Hepatology

Sequential Therapy for Helicobacter pylori Infection in Korea: Systematic Review and Meta-Analysis

(2013) Joon Sung Kim et al.   Gut and Liver

Sequential therapy or triple therapy for Helicobacter pylori infection in Asians: Systematic review and meta-analysis

(2013) Joon Sung Kim et al.   Clinics and Research in Hepatology and Gastroenterology

Antibiotic Resistance inHelicobacter pyloriStrains and its Effect onH. pyloriEradication Rates in a Single Center in Korea

(2013) Byoungrak An et al.   Annals of Laboratory Medicine

Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy

(2013) L. Gatta et al.   BMJ-British Medical Journal

Letter: the ethics of using inferior regimens in H. pylori randomised trials

(2012) D. Y. Graham et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Management ofHelicobacter pyloriinfection—the Maastricht IV/ Florence Consensus Report

(2012) Peter Malfertheiner et al.   GUT

Helicobacter pylori Infection: Sequential Therapy Followed by Levofloxacin-Containing Triple Therapy provides a Good Cumulative Eradication Rate

(2012) Marco Manfredi et al.   HELICOBACTER

Prevalence of Primary and Secondary Antimicrobial Resistance ofHelicobacter pyloriin Korea from 2003 through 2012

(2012) Jung Won Lee et al.   HELICOBACTER

Second-line Therapy With Levofloxacin After Failure of Treatment to Eradicate Helicobacter pylori Infection

(2012) Javier P. Gisbert et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough

(2011) J. P. Gisbert et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Gastric Atrophy and Intestinal Metaplasia before and after Helicobacter pylori Eradication: A Meta-Analysis

(2011) Jin Wang et al.   DIGESTION

Helicobacter pylori treatment in the era of increasing antibiotic resistance

(2010) D. Y. Graham et al.   GUT

Sequential Therapy or Triple Therapy for Helicobacter pylori Infection: Systematic Review and Meta-Analysis of Randomized Controlled Trials in Adults and Children

(2009) Luigi Gatta et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Sequential therapy vs. standard triple therapies forHelicobacter pyloriinfection: a meta-analysis

(2008) J. L. Tong et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Second-Line Rescue Therapy With Levofloxacin After H. pylori Treatment Failure: A Spanish Multicenter Study of 300 Patients

(2007) Javier P Gisbert et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY